POSTER SESSIONS
Scientific poster presentations will be displayed in the Marketplace (free and open to the public) during open hours from Friday, April 21, through Sunday, April 23. Poster presenters will be available at their poster for discussion and questions at the designated times.
POSTER TIMES
Friday, April 21: 2:00 - 4:00 PM
Saturday, April 22: 11:00 AM - 12:30 PM
Sunday, April 23: 11:00 AM - 12:30 PM
POSTERS
Fernanda Palhano-Fontes, M.D.
Comparing the Antidepressant Effects of Ayahuasca and Ketamine
2:00 PM - 4:00 PM, Friday, April 21
West Hall
Joseph Peter Barsuglia, Ph.D.
Characterization of Mystical Experiences Occasioned by 5-MeO-DMT-Containing Toad Venom and Comparison with Prior Psilocybin Studies
11:00 AM - 12:30 PM, Saturday, April 22
West Hall
David Egert, Ph.D.
Physiological Correlates of Anxiety Associated with a Life-Threatening Illness in Subjects Undergoing MDMA-Assisted Psychotherapy
11:00 AM - 12:30 PM, Sunday, April 23
West Hall
Benjamin Mudge, Ph.D. (candidate)
The Therapeutic Potential of Ayahuasca for People with Bipolar Disorder
2:00 PM - 4:00 PM, Friday, April 21
West Hall
Chris Timmermann, Ph.D. (candidate)
Effects of DMT on the Human Brain as Measured by EEG
2:00 PM - 4:00 PM, Friday, April 21
West Hall
Anthony S. Gabay, M.Sc., Ph.D. (candidate)
MDMA Modulates Behaviour in the Prisoner's Dilemma and Ultimatum Game
11:00 AM - 12:30 PM, Saturday, April 22
West Hall
Berra Yazar-Klosinski, PhD
Safety and Feasibility of MDMA-Assisted Therapy for Social Anxiety in Autistic Adults: Preliminary Findings from a MAPS-Sponsored Placebo-Controlled Phase 2 Pilot Study
11:00 AM - 12:30 PM, Saturday, April 22
West Hall
Collin Reiff
The Development of a Translational Study of 3,4-methylenedioxymethamphetamine (MDMA) Effects on Conditioned Fear Extinction
11:00 AM - 12:30 PM, Saturday, April 22
West Hall
Tanya Maté, ND
Ceremony and Dieta: Integration and Maximal Healing with Ayahuasca and other Master Plants
11:00 AM - 12:30 PM, Saturday, April 22
West Hall
Hayley Prescott, B.Sc.
Standardization of Banisteriopsis caapi: Towards an FDA-Approved Phase I Trial of B. caapi in Parkinson's Disease
11:00 AM - 12:30 PM, Sunday, April 23
West Hall
Michiko Mitsunaga-Whitten, M.S.W. (candidate)
A Correlative Analysis of Mystical Experience and Treatment Outcomes from MDMA-Assisted Psychotherapy for Treatment-Resistant PTSD
11:00 AM - 12:30 PM, Saturday, April 22
West Hall
Helen Harrison, B.A.
A Pilot Study of Oral Ketamine for Treatment-Resistant Depression
2:00 PM - 4:00 PM, Friday, April 21
West Hall
Joe Garand, M.A.
A Mixed-Methods Study of 2C-E's Potential for Self-Exploration and Healing
2:00 PM - 4:00 PM, Friday, April 21
West Hall
William Barone, Psy.D.
A Pilot Qualitative Investigation into the Experience and Views of Participants on Efficacy One Year Following a Study of MDMA-Assisted Psychotherapy for Adults with Treatment-Resistant PTSD
11:00 AM - 12:30 PM, Saturday, April 22
West Hall
Ethan Hurwitz, B.S.
A Comparison of Psilocybin-Occasioned vs. Naturally-Occurring Experiences of Personal Encounters with the Divine
11:00 AM - 12:30 PM, Sunday, April 23
West Hall
Henrique Fernandes Antunes Ph.D. (candidate)
Between Risks, Rights and Burdens: The Regulation Process of an Ayahuasca Church in the State of New Mexico
2:00 PM - 4:00 PM, Friday, April 21
West Hall
Jamie McAlpin R.N., B.S.N., and Christine Fitzsimmons, R.N.
Debunking Common Ibogaine Safety Myths
11:00 AM - 12:30 PM, Saturday, April 22
West Hall
Crystal Hare, B.Sc.
The Use of MDMA-Assisted Psychotherapy to Treat Health-Related Anxiety in Patients with Chronic Medical Illness: A Pilot Study Proposal
11:00 AM - 12:30 PM, Sunday, April 23
West Hall
Filip Tyls, M.D.
Dynamic Changes of Brain Networks Induced by Psilocybin: Multidimensional Approach to EEG Connectivity
2:00 PM - 4:00 PM, Friday, April 21
West Hall
Samuel Banister, Ph.D.
The Evolution of Synthetic Cannabinoid New Psychoactive Subtances
11:00 AM - 12:30 PM, Saturday, April 22
West Hall
Juan Acosta-Urquidi, Ph.D.
EEG Studies of the Acute Effects of N,N and 5-MeO- DMT
11:00 AM - 12:30 PM, Sunday, April 23
West Hall
Alan K. Davis, Ph.D.
Subjective Effectiveness of Ibogaine Treatment for Problematic Opioid Consumption: Short- and Long-Term Outcomes and Current Psychological Functioning
11:00 AM - 12:30 PM, Saturday, April 22
West Hall
Kathryn Chilton, Medical Student
EEG Brain Dynamics and Altered States of Consciousness During Sub-Anesthetic Ketamine Dose Administration in Healthy Adults
11:00 AM - 12:30 PM, Saturday, April 22
West Hall
Richard Idell, M.D.
Psilocybin for Treatment-Resistant Depression: From Bench to Bedside
11:00 AM - 12:30 PM, Sunday, April 23
West Hall
Benjamin J Malcolm, Pharm.D., M.P.H.
Changes in Withdrawal and Craving Scores in Subjects Undergoing Opioid Detoxification Utilizing Ibogaine
2:00 PM - 4:00 PM, Friday, April 21
West Hall
Ahnjili Zhuparris, M.Sc.
Pharmacological and Behavioral Interventions for Focus: The Comparison of Reversal Learning Under the Influence of Lysergic Acid Diethylmide (LSD), Methylphenidate (MPH), and Mindfulness
11:00 AM - 12:30 PM, Saturday, April 22
West Hall
Selma Holden, M.D., M.P.H., M.S.
The Association of Psychedelic Use and Opioid Use Severity Among Illicit Users in the United States
11:00 AM - 12:30 PM, Sunday, April 23
West Hall
Andrea Langlois, M.A.
Psychedelics, Entheogens, and Public Policy: Mapping a Path Forward
11:00 AM - 12:30 PM, Sunday, April 23
West Hall
Phillip Perl, B.S., M.P.H. (candidate)
A Pilot Qualitative Analysis of the Impact of Social Support in Long-Term Efficacy Following a Study of MDMA-Assisted Psychotherapy for Adults With Treatment-Resistant PTSD (Master's Thesis)
11:00 AM - 12:30 PM, Sunday, April 23
West Hall
Natalie L. Trent, Ph.D.
Subjective Effects of Salvia divinorum Use: A Retrospective Mixed Methods Approach
2:00 PM - 4:00 PM, Friday, April 21
West Hall
Steven Pennybaker, B.S.
Who is "Molly"? MDMA-Adulterants by Product Name and the Impact of Harm Reduction Services at "Raves"
11:00 AM - 12:30 PM, Sunday, April 23
West Hall
Michelle S. Thiessen, B.A. (hons.), M.A. (candidate)
Psychedelic Use and Intimate Partner Violence: Emotion Regulation Mediates Protective Effects
2:00 PM - 4:00 PM, Friday, April 21
West Hall
Rita Kočárová, M.Sc.
Human Studies with Psychedelics and Delirogens in the Former Czechoslovakia: Implications for Future Research
11:00 AM - 12:30 PM, Saturday, April 22
West Hall
Nese Devenot, Ph.D.
The Role of Experimental Language in Psychedelic Science Research
11:00 AM - 12:30 PM, Sunday, April 23
West Hall
Allison Feduccia, Ph.D.
MDMA-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: findings from MAPS-sponsored phase 2 clinical research trials
11:00 AM - 12:30 PM, Sunday, April 23
West Hall
Jerome Beck, Dr.P.H.
A Qualitative Follow-Up Study of MDMA-Assisted Psychotherapy for Veterans with Treatment-Resistant PTSD: Findings and Recommendations for Future Research
11:00 AM - 12:30 PM, Sunday, April 23
West Hall
Mina Pas, M.D.
Evaluation of Healing Potential of Ayahuasca on Psychopathology and General Well-Being
2:00 PM - 4:00 PM, Friday, April 21
West Hall
Oriana Mayorga, B.S.
Knowledge of MDMA and Risk Propensity Relating to Perception of MDMA-Assisted Psychotherapy in Young Adults
11:00 AM - 12:30 PM, Saturday, April 22
West Hall
Iker Puente, Ph.D.
A Comparison of the Subjective Effects of Different Psychedelics and Holotropic Breathwork Using the States of Consciousness Questionnaire (SCQ)
11:00 AM - 12:30 PM, Sunday, April 23
West Hall
Mauricio Diament
When Your Patient Takes Ayahuasca: What a Physician Should Know
11:00 AM - 12:30 PM, Sunday, April 23
West Hall
Todd Y., Santo Daime Member
Sober Living: The Recovery House in a New Light
2:00 PM - 4:00 PM, Friday, April 21
West Hall
Joseph Tafur, M.D.
The Potential Role of Epigenetics in Ayahuasca Shamanism
11:00 AM - 12:30 PM, Saturday, April 22
West Hall
Richard J. Zeifman, B.A.
Expanding Paradigms: The Case for Incorporating MDMA-assisted Psychotherapy Within Evidence-Based Treatments for Borderline Personality Disorder
11:00 AM - 12:30 PM, Sunday, April 23
West Hall
